Oric Pharmaceuticals, Inc.

Hong Wang

Xiaohui Du

F Anthony Romero

Stephane Ciblat

Paul Gibbons

Jared Moore

Lea Constantineau-Forget

Hiroyuki Kawai

Kejia Wu

Joanne Tan

Daniel Gordon Michael Shore

Jae Hyuk Chang

Chudi Ndubaku

Amit Nayyar

Vincent Albert

Dilan Emine Polat

Hugo De Almeida Silva

Disclosed herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, that are inhibitors of Polo Like Kinase 4 (PLK4). Also disclosed herein are pharmaceutical compositions comprising the compounds of Formula (I), or pharmaceutically acceptable salts thereof, and one or more pharmaceutically acceptable excipients. Further disclosed herein are methods of treating cancer in a subject in need thereof, comprising administering to the subject an amount of a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

Polo like kinase 4 inhibitors

Growing community of inventors

Montreal, Canada

Hong Wang